ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures
Zulekha A. Qadeer(University of California, San Francisco), David Valle‐García(Icahn School of Medicine at Mount Sinai), Dan Hasson(Icahn School of Medicine at Mount Sinai), Zhen Sun(Icahn School of Medicine at Mount Sinai), April Cook(Icahn School of Medicine at Mount Sinai), Christie B. Nguyen(Icahn School of Medicine at Mount Sinai), Aroa Soriano(Vall d'Hebron Institut de Recerca), Anqi Ma(Icahn School of Medicine at Mount Sinai), Lyra Griffiths(St. Jude Children's Research Hospital), Maged Zeineldin(St. Jude Children's Research Hospital), Dan Filipescu(Icahn School of Medicine at Mount Sinai), Luz Jubierre(Vall d'Hebron Institut de Recerca), Asif H. Chowdhury(Icahn School of Medicine at Mount Sinai), Orla Deevy(Icahn School of Medicine at Mount Sinai), Xiang Chen(St. Jude Children's Research Hospital), David Finkelstein(St. Jude Children's Research Hospital), Armita Bahrami(St. Jude Children's Research Hospital), Elizabeth Stewart(St. Jude Children's Research Hospital), Sara M. Federico(St. Jude Children's Research Hospital), Soledad Gallego(Vall d'Hebron Hospital Universitari), Fumiko Dekio(Icahn School of Medicine at Mount Sinai), Mary Fowkes(Icahn School of Medicine at Mount Sinai), David Meni(Memorial Sloan Kettering Cancer Center), John M. Maris(Children's Hospital of Philadelphia), William A. Weiss(University of California, San Francisco), Stephen S. Roberts(Memorial Sloan Kettering Cancer Center), Nai‐Kong V. Cheung(Memorial Sloan Kettering Cancer Center), Jian Jin(Icahn School of Medicine at Mount Sinai), Miguel F. Segura(Vall d'Hebron Institut de Recerca), Michael A. Dyer(St. Jude Children's Research Hospital), Emily Bernstein(Icahn School of Medicine at Mount Sinai)
Cited by 117Open Access